To include your compound in the COVID-19 Resource Center, submit it here.

Zelboraf vemurafenib regulatory update

Roche disclosed in its 1H11 earnings that it submitted applications for Zelboraf

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE